Parisi Rosario, Secco Gioel Gabrio, Di Eusanio Marco, Fattori Rossella
Cardiology and Interventional Cardiology Unit, AO Ospedali Riuniti Marche Nord, Pesaro, Piazzale Cinelli 1, 61121 Pesaro, Italy.
Cardiac Surgery Unit, G. Mazzini Hospital, Piazza Italia 1, 64100 Teramo, Italy.
Diseases. 2015 Jul 27;3(3):159-166. doi: 10.3390/diseases3030159.
Over the last decades, improvement of medical and surgical therapy has increased life expectancy in Marfan patients. Consequently, the number of such patients requiring secondary interventions on the descending thoracic aorta due to new or residual dissections, and distal aneurysm formation has substantially enlarged. Surgical and endovascular procedures represent two valuable options of treatment, both associated with advantages and drawbacks. The aim of the present manuscript was to review endovascular outcomes in Marfan syndrome and to assess the potential role of Thoracic Endovascular Aortic Repair (TEVAR) in this subset of patients.
在过去几十年中,医学和外科治疗的进步提高了马凡综合征患者的预期寿命。因此,因新发或残留夹层以及远端动脉瘤形成而需要对胸降主动脉进行二次干预的此类患者数量大幅增加。外科手术和血管内介入手术是两种有价值的治疗选择,二者都有优缺点。本手稿的目的是回顾马凡综合征的血管内治疗结果,并评估胸主动脉腔内修复术(TEVAR)在这类患者中的潜在作用。